11:09 AM EDT, 08/06/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were trending higher late Tuesday morning following Monday's sell-off, rising 0.7% to 1,374.04 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biotech firm Evaxion Biotech ( EVAX ) and pharmaceutical company Novo Nordisk ( NVO ) , which rose 3.3% and 3.2% respectively. They were followed by semiconductor company Sequans Communications ( SQNS ) and biopharmaceutical company Genfit ( GNFT ) , which increased 2.7% and 2.5% respectively.

The decliners from continental Europe were led by biopharmaceutical company Cellectis ( CLLS ) and financial services company Banco Bilbao Vizcaya Argentaria ( BBVA ) , which fell 2.9% and 1.1% respectively. They were followed by accommodation booking company trivago (TRVG) and internet browser company Opera (OPRA), which dropped 0.5% and 0.2% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company Amarin ( AMRN ) and cruise line operator Carnival (CUK), which increased 3.8% and 3.3% respectively. They were followed by biopharmaceutical company Verona Pharma ( VRNA ) and telecommunications operator Vodafone Group ( VOD ) , which were up 2.6% and 1.9% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company TC Biopharm ( TCBP ) and biotech firm Autolus Therapeutics ( AUTL ) , which lost 6.6% and 4.7% respectively. They were followed by pharmaceutical company GSK (GSK) and biopharmaceutical company Adaptimmune Therapeutics ( ADAP ) , which were down 1.5% and 0.04% respectively.